Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Patent
1996-12-13
1999-02-02
Low, Christopher S. F.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
424 91, 424 931, 424 932, 4353201, 435 691, 435 4, 435 6, 435 721, 435 74, 435455, 435325, A61K 4900
Patent
active
058660984
ABSTRACT:
The present invention concerns a novel paracrine signaling assay.
REFERENCES:
patent: 5075227 (1991-12-01), Hagen
patent: 5585087 (1996-12-01), Lustig et al.
Watson et al. 1987 in: Molecular Biology of the Gene, Fourth Edition, Benjamin/Cummings Publishing Co., Menlo park, CA, p. 313.
Patten et al. 1974 in:Foundations of Embryology, Third Edition, McGraw-Hill Book Company, New York, NY, pp., 22, 24, 25, 342, 349-350.
Jessell et al. 1992, Cell 68: 257-270.
Pederson (ed.) 1994, in: Current Topics in Developmental Biology, vol. 29, Academic Press, San Diego, CA, p. 156.
Kirschner Marc W.
Lustig Kevin D.
Arnold Beth E.
Low Christopher S. F.
President and Fellows of Harvard College
Vincent Matthew P.
LandOfFree
Assay for identifying extracellular signaling proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay for identifying extracellular signaling proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for identifying extracellular signaling proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114435